Canaccord Genuity Maintains Buy on AtriCure, Lowers Price Target to $74
Canaccord Genuity analyst William Plovanic maintains AtriCure (NASDAQ:ATRC) with a Buy and lowers the price target from $81 to $74.
Needham Reiterates Buy on AtriCure, Maintains $58 Price Target
Needham analyst Mike Matson reiterates AtriCure (NASDAQ:ATRC) with a Buy and maintains $58 price target.
Earnings Scheduled For February 21, 2023
Companies Reporting Before The Bell
• Sohu.com (NASDAQ:SOHU) is likely to report earnings for its fourth quarter.
Earnings Outlook For AtriCure
AtriCure (NASDAQ:ATRC) is set to give its latest quarterly earnings report on Tuesday, 2023-02-21. Here’s what investors need…
Needham Maintains Buy on AtriCure, Raises Price Target to $58
Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $55 to $58.
AtriCure Q3 EPS $(0.27) Misses $(0.25) Estimate, Sales $83.20M Beat $81.33M Estimate
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.25) by 8 percent. This is a 17.39 percent decrease over losses of $(0.23) per share from the same
5 Analysts Have This to Say About AtriCure
Within the last quarter, AtriCure (NASDAQ:ATRC) has observed the following analyst ratings:
Needham Maintains Buy on AtriCure, Raises Price Target to $65
Needham analyst Mike Matson maintains AtriCure (NASDAQ:ATRC) with a Buy and raises the price target from $55 to $65.
AtriCure Q2 EPS $(0.32) Misses $(0.29) Estimate, Sales $84.50M Beat $79.67M Estimate
AtriCure (NASDAQ:ATRC) reported quarterly losses of $(0.32) per share which missed the analyst consensus estimate of $(0.29) by 10.34 percent. This is a 6.67 percent decrease over losses of $(0.30) per share from the
Earnings Scheduled For August 2, 2022
Companies Reporting Before The Bell
• Ferrari (NYSE:RACE) is expected to report quarterly earnings at $1.27 per share on revenue of $1.22 billion.